GlassScriptPhysician profile
Hasan Murshed
NPI 1447210927
$1,228.15
in general payments reported to CMS, 2019-2025
29 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $160 · 2021: $291 · 2022: $102 · 2023: $70.72 · 2024: $193 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $147.27 | 2019 | |
| Novocure INC. | $122.85 | 2023-2025 | Optune, Optune Gio |
| Amgen INC. | $111.99 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $110.32 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $70.06 | 2021-2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $65.98 | 2020-2024 | Imfinzi |
| Janssen Biotech, INC. | $54.76 | 2020-2024 | Erleada, Akeega |
| Jazz Pharmaceuticals INC. | $44.63 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.17 | 2024-2025 | |
| Dova Pharmaceuticals | $38.21 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $35.77 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $34.97 | 2024 | |
| Genzyme Corporation | $34.66 | 2020-2021 | |
| Telix Pharmaceuticals | $32.77 | 2025 | Illuccix |
| United Imaging Healthcare North America, INC. | $28.74 | 2025 | N/A |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.57 | 2019-2021 | |
| Myovant Sciences INC. | $26.92 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $25.29 | 2022 | |
| Astellas Pharma US INC | $21.07 | 2020 | |
| Tempus Ai, INC | $20.27 | 2025 | Xt Cdx |
| Medtronic, INC. | $18.98 | 2025 | Osteocool Rf Ablation System |
| Myriad Genetic Laboratories, INC. | $16.94 | 2022 | |
| Incyte Corporation | $16.49 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 2021 | |
| Bioprotect Medical, INC. | $14.39 | 2025 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $13.48 | 2019 | |
| Blue Earth Diagnostics | $13.45 | 2021 | |
| Rgh Enterprises LLC | $12.97 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Murshed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.